Should you buy, hold, or sell these ASX 200 stars of FY25?

After exceptional share price growth, should you hold on to your outperformers or take your profits while the going is good?

A woman has a quizzical look on her face as though she is deciding something in the foreground of a backdrop featuring five stars, like the Australian five star energy rating system.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's a question that many S&P/ASX 200 Index (ASX: XJO) shares investors would be familiar with.

After exceptional share price growth, should you hold on to your outperformers or take your profits while the going is good?

The following four ASX 200 stocks delivered strong share price gains in FY25.

Market analysts tell us what they think investors should do with these holdings now.

After amazing growth, should you hang on to these ASX 200 stocks?

Wesfarmers Ltd (ASX: WES)

The Wesfarmers share price rose by 30% in FY25.

On Tuesday, Wesfarmers shares are 1.64% higher at $86.63 at the time of writing.

Macquarie has a neutral rating on Wesfarmers shares and a price target of $82. This is akin to a hold rating.

In a recent note, Macquarie said:

Management continues to execute, with the stock's valuation continuing to be driven by the key Bunnings and Kmart retail businesses.

We acknowledge the upside risk from new adjacencies, although see much of this factored into the current share price.

Sigma Healthcare (ASX: SIG)

In FY25, Sigma Healthcare was one of nine ASX 200 shares that more than doubled in value. 

The ASX healthcare stock ripped 135% higher in FY25.

Today, the Sigma Healthcare share price is down 0.35% to $2.86 at the time of writing.

Macquarie has an underperform rating on Sigma Healthcare shares.

The broker explains:

We retain our Underperform recommendation on SIG as we believe the market is giving too much credit on growth prospects (although we still expect sector leading earnings growth).

The first result as a combined entity with Chemist Warehouse will be telling on growth potential and franchisee economics.

Sigma Healthcare will report its results on Wednesday, 27 August.

Hub24 Ltd (ASX: HUB)

Hub24 shares were among the 5 best ASX 200 financial stocks of FY25 for share price growth.

Shares in the investment and superannuation platform provider rose 92% in FY25.

The Hub24 share price is currently $108.11, up 1.26%.

Bell Potter has a buy rating on Hub24 with a 12-month price target of $115.

This implies further potential upside of 6%.

Xero Ltd (ASX: XRO)

Xero shares were among the 5 best-performing ASX 200 tech shares of FY25.

Shares in the cloud-based accounting software provider rose 32% in FY25.

The Xero share price is currently $177.55, up 1.25%.

Morgans has a hold rating on this ASX 200 tech stock.

Analyst Damien Nguyen suggests that new investors wait for a dip before buying Xero shares.

Nguyen commented on The Bull:

While business fundamentals remain solid and are expected to deliver strong growth over the coming years, potential investors may want to wait for a more attractive entry point.

For existing holders, it makes sense to stay invested and monitor how the company executes its growth plans.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Hub24, Macquarie Group, Wesfarmers, and Xero. The Motley Fool Australia has positions in and has recommended Macquarie Group and Xero. The Motley Fool Australia has recommended Hub24 and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.
Opinions

Where I'd invest $10,000 in 2026 in ASX shares aiming to beat the market

These businesses look like very appealing buys today.

Read more »

a woman with lots of shopping bags looks upwards towards the sky as if she is pondering something.
Opinions

The pros and cons of buying Zip shares in 2026

There are positive and negative aspects about Zip shares right now…

Read more »

Two people lazing in deck chairs on a beautiful sandy beach throw their hands up in the air.
Dividend Investing

A dividend giant I'd buy over BHP shares right now!

This stock is much more appealing to me than BHP. Here’s why…

Read more »

Super profit tax ASX miners one hundred dollar notes floating around representing asx share price growth
Dividend Investing

I'd buy 21,819 shares of this ASX stock to aim for $200 a month of passive income

This business is an impressive option for significant dividend cash flow.

Read more »

A stressed businessman in a suit shirt and trousers sits next to his briefcase with his head in his hands while the ASX boards behind him show BNPL shares crashing
Opinions

2 buys and 1 sell for investors worried about an ASX market crash in 2026

Here's how to prepare.

Read more »

A handful of Australian $100 notes, indicating a cash position
Dividend Investing

1 ASX dividend stock down 36% I'd buy right now

This stock may be trading far too cheap.

Read more »

a pot of gold at the end of a rainbow
Opinions

Why this could be the easiest way to become a millionaire with shares on the ASX

This investment could offer everything an investor is looking for.

Read more »

Rising green bar graph with an arrow and a world map, symbolising a rising share price.
Opinions

2 ASX shares to buy and hold for the next decade!

These two businesses have a very exciting outlook.

Read more »